Increase in fiber density for immunoreactive serotonin, substance P, enkephalin and thyrotropin-releasing hormone occurs during the early presymptomatic period of motoneuron disease in Wobbler mouse spinal cord ventral horn

Neuroscience Letters

Volumn 260, Issue 3, 1999, Pages 196-200

  Bose, P ^a   Vacca Galloway, L L ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Immunocytochemistry; Motoneuron loss; Neuropeptides; Sprouting

Indexed keywords

LEUCINE ENKEPHALIN; METENKEPHALIN; PROTIRELIN; SEROTONIN; SUBSTANCE P;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITY; IMMUNOCYTOCHEMISTRY; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD VENTRAL HORN;

AGING; ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; ENKEPHALINS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURON DISEASE; NERVE FIBERS; SEROTONIN; SPINAL CORD; SUBSTANCE P; THYROTROPIN-RELEASING HORMONE;

EID: 0033524963     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00959-8     Document Type: Article

References (21)

1. Andrews, J.M. and Andrews, R., The comparative neuropathology of motor neuron disease. In Andrews, J.M., Johnson, M.T. and Brazier, M.A.B. (Eds), Amyotrophic Lateral Sclerosis: Recent Research Trends, Academic Press, New York, 1976, pp. 181-216.
2. Bose P., Fielding R., Ameis K.M., Vacca-Galloway L.L. A novel behavioral method to detect motoneuron disease in Wobbler mice aged three to seven days old. Brain Res. 813:1998;334-342.
3. Bose, P., Wobbler mouse: early detection of motoneuron disease, therapeutic evaluation of nutrition, neuropeptides and their antagonists, and the effects on neuronal sprouting in cervical spinal cord, Ph.D. thesis, Faculty of Medicine, University of Hong Kong, 1997.
4. Duchen L.W., Strich S.J. An hereditary motor neuron disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. J. Neurol. Neurosurg. Psychiatry. 31:1968;535-542.
5. Falconer D.S. Wobbler (wr), Mouse News Lett. 15:1956;23.
6. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between (ABC) and unlabelled antibody (PAP) procedure. J. Histochem. Cytochem. 29:1981;1349-1353.
7. Ishiyama T., Klinkosz B., Pioro E.P., Mitsumoto H. Genetic transfer of the wobbler gene to a C57BL/6J×NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment. Exp. Neurol. 148:1997;247-255.
8. Lange D.J., Good P.F., Bradley W.G. A therapeutic trial of gangliosides and thymosin in the Wobbler mouse model of motor neuron disease. J. Neurol. Sci. 61:1983;211-216.
9. LaVail J.H., Koo E.H., Dekker N.P. Motoneuron loss in the abducens nucleus of wobbler mice. Brain Res. 404:1987;127-132.
10. Leestma J.E. Animal model of human disease: Werdnig-Hoffmann disease (infantile spinal muscular atrophy). Am. J. Pathol. 100:1980;821-824.
11. Mitsumoto H., Ikeda K., Klinkosz B., Cedarbaum J.M., Wong V., Lindsay R.M. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science. 265:1994;1107-1110.
12. Papapetropoulos T.A., Bradley W.G. Spinal motor neurons in murine muscular dystrophy and spinal muscular atrophy. A quantitative histological study. J. Neurol. Neurosurg. Psychiatry. 35:1972;60-65.
13. Shi J., Vacca Galloway L.L. Thyrotropin-releasing hormone (TRH) neurons sprout in cervical spinal cord of Wobbler mouse. Brain Res. 626:1993;83-89.
14. Shu S.Y., Ju G., Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85:1988;169-171.
15. Sillevis Smitt P.A., de Jong J.M. Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J. Neurol. Sci. 91:1989;231-258.
16. Ukabam C.U. A Golgi-Cox study of the hypoglossal nucleus of "wobbler" and normal mice. Ric. Clin. Lab. 18:1988;313-318.
17. Vacca Galloway L.L., Steinberger C.C. Substance P neurons sprout in the cervical spinal cord of the wobbler mouse: a model for motoneuron disease. J. Neurosci. Res. 16:1986;657-670.
18. Vacca-Galloway, L.L., Zhang, Y.Q., Bose, P. and Zhang, S.H., Alterations in the number of motoneurons containing immunoreactive calcitonin gene-related peptide (CGRP) and choline acetyltransferase (ChAT) in the cervical spinal cord of the Wobbler mouse during the development of the motoneuron disease. In Procedures in Microscopy and Microanalysis, Jones and Begell, New York, 1995, pp. 970-971.
19. Vacca-Galloway, L.L., Bose, P. and Ameis, K.M., Neurotrophins (CNTF, BDNF) administered to pre-symptomatic Wobbler mice relieve symptoms of motoneuron disease. In Techykinins in Health and Disease, Abstract 48, 1997, p. 49.
20. Visser, T.J., Klootwilk, W., Doctor, R. and Henneman, G., A different approach to the radioimmunoassay of thyrotropin-releasing hormone. In Radioimmunoassay and Related Procedures in Medicine, National Atomic Energy Agency, Vienna, 1977, pp. 469-477.
21. Zhang Y.Q., Vacca Galloway L.L. Decreased immunoreactive (IR) calcitonin gene-related peptide correlates with sprouting of IR-peptidergic and serotonergic neuronal processes in spinal cord and brain nuclei from the Wobbler mouse during motoneuron disease. Brain Res. 587:1992;169-177.